Search

Your search for "DRIO" returned the following results.
Filter Results:
InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Strategic Reorganization, CCO Appointment

June 5, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a strategic reorganization designed to streamline leadership and focus the organization on accelerating its commercialization efforts. The move reflects Dario’s commitment to bringing its innovative solutions to the market faster, maximizing customer impact, and driving the organization to profitability. To achieve this […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q1 2024 Results

May 15, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today reported financial results for the first quarter 2024. Among the highlights, the company reported first quarter revenue of $5.8 million, reflecting a 59% increase over the fourth quarter of 2023 primarily resulting from an increase in B2B2C revenues. “In the first quarter, our […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q1 2024 Financial, Operational Results

May 7, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is planning to release its financial results for the first quarter 2024, the period ended March 31, 2024. According to the announcement, the company will release the report on May 15, 2024, before the market opens. In addition, the company has scheduled a conference […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Two Studies Evaluating Impact of Digital Behavioral Health Program for Teens

April 25, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has new research being published in the leading peer-reviewed journal for digital health and medicine, the “Journal of Internet Medicine.” The research is based on a quasi-randomized study that demonstrates the value of Dario’s integrated approach in providing a solution for members to manage diabetes, […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Two Contracts to Provide Integrated Cardiometabolic Solutions

April 18, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has announced that two employers, a national supply chain company and a regional education organization, have selected its integrated chronic condition management solutions. According to the announcement, beginning in the second quarter of 2024, Dario will provide solutions to improve outcomes for employees with […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Two Studies Evaluating Impact of Digital Behavioral Health Program for Teens

April 10, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has published two studies in the leading peer-reviewed journal for digital health and medicine, the “Journal of Internet Medicine.” The studies include a randomized controlled trial (“RCT”) demonstrating the impact of a digital stress reduction program for teens. According to the announcement, the first […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q4 2023 Results, Conference Call

April 2, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced that it will release its financial results for the fourth quarter ended Dec. 31, 2023, before market opens on Thursday, March 28, 2024. At 8:30 a.m. Eastern Time on that same day, the company will host a conference call and webcast. […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q4, FY 2023 Financial Report, Operational Update

March 28, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on its fourth-quarter and full-year 2023 financial results; the company also releases a corporate and commercial update. Highlights of the report include $20.4 million full-year 2023 revenue, down from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q4 2023 Results

March 21, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced that it will release its financial results for the fourth quarter of fiscal 2023 for the three months ended Dec. 31, 2023, on Thursday, Mar. 28, 2024, before market open. Additionally, DarioHealth’s CEO Erez Raphael and President Rick Anderson will host […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents New Research from Two Studies at International Conference

March 13, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, recently presented two new clinical studies at the 17th International Conference on Advanced Technologies and Treatments for Diabetes (“ATTD”) 2024. The conference was held in Florence, Italy, on March 6–9, 2024. According to the announcement, one of the studies presented at the three-day gathering is […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Executive Team Members to Participate at Upcoming Cowen Annual Healthcare Conference

February 28, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be participating in the 44th annual Cowen Healthcare Conference. The three-day event is slated for March 4–6, 2024, in Boston. During the conference, DarioHealth CEO Erez Raphael and president Rick Anderson will be featured in a fireside chat scheduled to begin at 10:30 […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Key Acquisition, Creates Comprehensive Digital Health Platform for Chronic Conditions

February 21, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has acquired Twill Inc., a leader in digital-led care. According to the announcement, the acquisition will allow the company to “create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with Regional Union for Diabetes, Hypertension, Weight-Management, GLP-1 Support

January 11, 2024

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, announced a new contract to provide its proprietary cardiometabolic solution to a regional union. According to the announcement, the new contract is evidence that DRIO’s integrated solution to support improved whole health is gaining traction in the public and labor market. The union, which […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp.’s (NASDAQ: DRIO) Solutions Selected by National Employer

December 5, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a new contract to provide cardiometabolic and GLP-1 solutions to a national employer beginning in January 2024. The national logistics company selected Dario to deliver integrated support for employees living with diabetes, pre-diabetes, weight management and hypertension, while also providing a tailored […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Hypertension Offering Selected by Blue Shield of California

November 29, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has been selected by Blue Shield of California to expand the nonprofit health plan’s services. According to the announcement, Blue Shield of California is adding Dario’s at-home solution for high blood pressure, or hypertension, that combines personalized health coaching and tech-enabled monitoring. The addition […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks New Cardiometabolic Solution Contract with National Company

November 27, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has entered into a new contract outlining plans to provide is cardiometabolic solution to an employer. The contract will begin in January 2024. The new contract is the latest is a growing number of similar agreements, indicating that demand for Dario’s integrated solutions continues […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) New Research Sheds Light on Mediators of Improved Outcomes in Dario Users

November 21, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced two new analyses presented by Sanofi U.S. demonstrating two mediators associated with improved clinical and economic results in Dario users. According to the announcement, presentations by Sanofi U.S. at the Diabetes Technology Society (“DTS”) annual conference, held Nov. 2 – 4, examined […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Study Showing Connection Between Increased Physical Activity, Reduced Blood Glucose

November 13, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on new research presented last week at the Diabetes Technology Society 2023 Meeting. According to the announcement, the new study demonstrates the value of associating physical activity tracking alongside blood sugar tracking for people living with diabetes and prediabetes; the results emphasize […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q3 2023 Results

November 2, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the third quarter 2023 and provided a corporate and commercial update. “As we discussed during our recent investor day, our revenue generally comes from three sources, our historical direct to consumer (‘B2C’) business, recurring revenue from health plans and […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Digital Health Solution Indicates Less-Costly Use of Hospital-Related Utilization, Study Shows

October 17, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on award-winning new research conducted by Sanofi U.S. that indicates the company’s ability to reduce costs through lower utilization of expensive healthcare resources. Sanofi US reported the research at the Academy of Managed Care Pharmacy’s 2023 annual conference Nexus (“AMCP-Nexus”). According to […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Selected as Preferred Partner by Top Five National Employee Benefits Consulting Firm

October 5, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has announced a new strategic partnership with a top five national employee benefits consulting firm, to become the preferred digital health and chronic condition solution partner for its national employer clients. According to the announcement, the firm selected Dario for its proven ability to […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Showcase Rise of Digital Health at Upcoming Investor Day

October 3, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced that it will host an in-person investor day in New York. The event is slated to take place beginning at 11 a.m. ET on Oct. 17, 2023, at the offices of Sullivan & Worcester LLP. Interested parties should visit https://ibn.fm/Bal6S to pre-register […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces New Research Evidencing Value of Digital Behavior Health Programs

September 27, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has announced new findings published in the Journal of Medical Internet Research (“JMIR”) demonstrating the impact of coaching and breathing exercises as part of the Dario digital behavioral health program for members living with depression or anxiety. The study analyzed the data of participants […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes New Research Backing Its Approach to Outcome-Based Engagement

August 24, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced new research presented at the ADCES23 Annual Conference that took place earlier this month in Houston, Texas. According to the announcement, the research demonstrates Dario’s ability to sustainably improve health outcomes for users with diabetes over a two-year period. “Dario’s solutions are […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with PlanSource to Provide Key Digital Health Solutions

August 15, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has inked a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology. The agreement, which expands Dario’s reach in the employer market, calls for the company to offer integrated digital health solutions to more than 5 million consumers. Dario’s […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q2 2023 Results

August 10, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the second quarter 2023 and provided a corporate and commercial update. “During the second quarter, we saw a continuation of the many positive trends that have contributed to our improved financial profile, including growing revenue contribution from highly scalable […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Agreement with Large Regional Health Plan

August 8, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced the expansion of its partnership with a large regional health plan to deliver highly personalized digital health solutions to plan members living with diabetes. The launch is anticipated to take place in the first quarter of 2024. “Our ability to engage members […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q2 2023 Results, Conference Call and Webcast

August 3, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced that it will release its financial results for the second quarter ended June 30, 2023, before market opens on Thursday, Aug. 10, 2023. Also on Aug. 10, the company will host a conference call and webcast at 8:30 a.m. Eastern Time, led […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Behavior Program to Support Weight Loss, Better Health

August 2, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is offering a new program designed to provide support for individuals using GLP-1s and other anti-obesity drugs. The program is designed to support changes in behavior and help users leverage the full potential of medications while improving overall health; the program also has potential […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Shares New Research Supporting Significant Medical Costs Savings for Dario Users

July 26, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a new analysis by Sanofi U.S. demonstrating a significant reduction in the cost of care for Dario users compared to non-users living with type 2 diabetes. According to the announcement, the study used matched claims to show an estimated $5,077 in medical […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Large Regional Health Plan to Client List, Reports on Q2 2023 Preliminary Results

July 24, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has added a new agreement with a large regional health plan to its client list. According to the announcement, DRIO will deliver highly personalized digital health solutions to more than 160,000 plan members living with hypertension; the plan will launch this month. DRIO noted […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Key Research Presented at ABA Scientific Sessions

June 26, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, reported on a retrospective cohort study at the recent American Diabetes Association (“ABA”) 83rd Scientific Sessions. According to the announcement, the study analyzed real-world data of Dario users against matched controls, with results showing significant improvements in HbA1c for Dario users with serious diabetes. […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Two New Contracts for Integrated Solutions

June 7, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced two new employer contracts for the company’s full suite of integrated solutions. According to the update, the new accounts are scheduled to launch in the second half of 2023. “Managing the rising cost of chronic conditions with a significant return on investment […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO to Present at Upcoming Stifel Virtual Cross Sector Insight Conference

June 1, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be attending and participating in the Stifel 2023 Virtual Cross Sector Insight Conference. The two-day event is scheduled to be held in Boston on June 6–7, 2023. According to the announcement, DarioHealth president Rick Anderson will be presenting at the conference; his presentation […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Solutions to MedOne Members

May 18, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global health market, and MedOne Pharmacy Benefit Solutions (“PBM”), a national leader in modern pharmacy benefits management, today announced a new agreement to integrate Dario’s suite of digital health solutions as a complement to MedOne’s digital diabetes solution, the Diabetes Care Path. According to the update, the collaboration […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q1 Financial and Operating Results

May 11, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced financial results for the first quarter 2023 and provided a corporate and commercial update. “During the first quarter, we continued to improve the financial profile of the company as we capitalized on the growing demand for digital health solutions in the […]

InvestorNewsBreaks

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Research Presented at Leading Global Conference for Health Economics

May 9, 2023

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, announced the presentation of research at ISPOR 2023, the leading global conference for health economics and outcomes research. The conference was on May 7–10, 2023, in Boston. The research presented came from a retrospective cohort study that analyzed real-world data of users and nonusers […]

No ResultsNo content matches your search/filter.

 

 

 

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).